Printer Friendly

Browse Monoclonal antibodies topic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
MacroGenics announces MGC018 publication in Molecular Cancer Therapeutics. Sep 23, 2020 259
MacroGenics announces $15M milestone triggered under Incyte agreement. Sep 21, 2020 192
MacroGenics presents MGD019 Phase 1 data at ESMO. Sep 20, 2020 269
Regeneron, Sanofi present 'positive' data for Libtayo monotherapy in BCC. Sep 18, 2020 365
Agenus initiates rolling BLA submission of balstilimab for cervical cancer. Sep 18, 2020 153
MorphoSys AG and I-Mab receive MOR210/TJ210 Investigational New Drug approval. Sep 18, 2020 196
MorphoSys AG and I-Mab receive MOR210/TJ210 Investigational New Drug approval. Sep 18, 2020 192
US Regulator Clears MorphoSys And I-Mab Tumour Treatment Application. Sep 18, 2020 227
Tiziana Life Sciences to conduct study on nasal Foralumab in COVID-19 patients. Sep 17, 2020 239
Celltrion Receives Korean MFDS Approval to Initiate Phase II/III Pivotal Trial of an Anti-COVID-19 Monoclonal Antibody Treatment Candidate, CT-P59. Sep 17, 2020 479
Eli Lilly's COVID-19 antibody treatment shows signs of treating infection. Sep 16, 2020 351
Kindred Biosciences: Primary objectives of KIND-030 study were met. Clinical report Sep 16, 2020 167
Humanigen, Lonza Announce Team to Expand Manufacturing of Humanigen's COVID-19 Therapeutic Candidate Lenzilumab. Sep 15, 2020 315
Humanigen And Lonza Team To Expand Manufacturing Of Covid-19 Treatment. Sep 15, 2020 188
Celltrion Touts Positive Interim Results from Phase I Trial of CT-P59, an Anti-COVID-19 Monoclonal Antibody Treatment Candidate. Sep 11, 2020 418
Manifold Bio announces USD5.4m from seed round to bring multiplexed measurement to drug discovery. Sep 9, 2020 199
Manifold Bio announces USD5.4m from seed round to bring multiplexed measurement to drug discovery. Sep 9, 2020 203
Diomics Aims to Nose Out Coronavirus Ahead of Vaccines with Nasal Spray That Delivers Monoclonal Antibody Protection. Sep 9, 2020 352
Kitov Pharmaceuticals doses first patient in Phase 1/2 trial of NT219. Sep 8, 2020 315
Exelixis, Catalent enter collaboration to develop ADCs. Sep 8, 2020 160
AbbVie, I-Mab Enter Into Global Strategic Partnership for Differentiated Immuno-oncology Therapy. Sep 8, 2020 816
The week in coronavirus: GlaxoSmithKline starts trials on treatment and vaccine; Zoom posts massive revenue growth; Virgin Atlantic gets rescue deal approved but cuts more jobs... Financial report Sep 5, 2020 613
AbbVie, I-MAB enter into global strategic partnership. Sep 4, 2020 281
Kitov Pharmaceuticals receives notice of intention to grant two patents in China. Sep 4, 2020 332
Humanigen says lenzilumab demonstrated 80% reduction in relative risk of invasive mechanical ventilation and/or death in coronavirus patients. Sep 2, 2020 616
Twist Bioscience announces SARS-CoV-2 neutralizing data from antibody program. Sep 2, 2020 175
US FDA Clears Omeros' Investigational New Drug Application for OMS906. Sep 2, 2020 694
Antibodies promising in fight against COVID-19. Sep 1, 2020 265
FDA grants Priority Review of Melflufen for Patients with Triple-Class Refractory Multiple Myeloma. Sep 1, 2020 394
Omeros IND for OMS906 cleared by FDA. Aug 31, 2020 161
Vir Biotechnology, GSK begin Phase 2/3 study of COVID-19 antibody treatment. Aug 31, 2020 524
IN BRIEF: GlaxoSmithKline And Vir Dose First Patient In Covid-19 Trial. Aug 31, 2020 163
AstraZeneca kicks off in-human trial for coronavirus treatment using monoclonal antibodies. Aug 26, 2020 422
Tiziana Life Sciences hails key US patent approval that provides added protection for COVID-19 drug. Aug 25, 2020 321
AstraZeneca starts trial of antibody medication that prevents and treats Covid-19 infections; Drug has the potential to act as a preventative for people exposed to the virus as well as to treat patients already infected. By, Brett Gibbons Aug 25, 2020 336
LONDON BRIEFING: Astra Starts Trial Of Potential Covid-19 Treatment. Aug 25, 2020 1287
TOP NEWS: AstraZeneca Doses First Patient In Covid-19 Treatment Trial. Aug 25, 2020 401
UK TOP NEWS SUMMARY: AstraZeneca Commences Covid-19 Drug Trial. Aug 25, 2020 1147
Tiziana Life Sciences hails key US patent approval that provides added protection for COVID-19 drug. Aug 25, 2020 323
AstraZeneca's new COVID-19 experimental antibody treatment given to volunteers. Aug 25, 2020 183
AstraZeneca's new COVID-19 experimental antibody treatment given to volunteers. Aug 25, 2020 179
AstraZeneca initiates Phase 1 trial of monoclonal antibody combination for COVID. Aug 25, 2020 210
IN BRIEF: Tiziana Life Sciences Gets US Patent On TZLS-501 In Covid-19. Aug 24, 2020 153
Tiziana says US Patent and Trademark Office grants patent on use and methods of treatment of Crohn's disease with Foralumab. Aug 19, 2020 523
Tiziana says US Patent and Trademark Office grants patent on use and methods of treatment of Crohn's disease with Foralumab. Aug 19, 2020 521
Amplyx Pharmaceuticals doses first patient in MAU868 phase two clinical trial. Clinical report Aug 18, 2020 160
Amplyx Pharmaceuticals doses first patient in MAU868 phase two clinical trial. Clinical report Aug 18, 2020 156
Eli Lilly, Innovent announce global expansion of TYVYT licensing agreement. Aug 18, 2020 410
Tiziana jumps 5% after announcing Crohn's disease treatment patent. Aug 18, 2020 222
DSG and Bestat Partner in Building COVID-19 Clinical Trials in Singapore. Aug 18, 2020 378
US FDA Approves Roche's Enspryng As Optica Spectrum Disorder Treatment. Aug 17, 2020 209
Cerecor announces publication highlighting the role of LIGHT in COVID-19 ARDS. Aug 13, 2020 307
Monopar Therapeutics to advance development of novel triage test for COVID-19. Aug 12, 2020 363
IAVI and Wellcome Issue a Global Call to Action: Monoclonal Antibodies for COVID-19 and Other Diseases Could Save Millions of Lives. Aug 11, 2020 752
AnaptysBio says etokimab did not demonstrate significance over placebo in study. Aug 10, 2020 697
Omeros Touts Results of Study Evaluating Narsoplimab for Treatment of COVID-19-Associated Acute Respiratory Distress Syndrome. Aug 10, 2020 832
Humanigen Expands Phase III Study of Lenzilumab in COVID-19 to Brazil. Report Aug 10, 2020 531
Omeros reports recovery, survival of all COVID patients in study of narsoplimab. Aug 10, 2020 310
TOP NEWS: US Regulator Approves Glaxo's Blenrep As Myeloma Treatment. Aug 6, 2020 233
Tiziana Life Sciences upbeat on potential for coronavirus treatment. Aug 6, 2020 447
Tiziana Life Sciences unveils plans to raise US$57.25mln from US investors. Aug 4, 2020 377
Tiziana Life Sciences unveils plans to raise US$57.25mln from US investors. Aug 4, 2020 375
MorphoSys announces FDA approval of Monjuvi, Lenalidomide combo. Aug 2, 2020 223
Tiziana Life Sciences makes patent application covering nasally-administered and orally taken Foralumab; shares spike 24%. Aug 1, 2020 462
Tiziana Life Sciences 'very excited' about potential for nasal delivery of Foralumab for coronavirus. Aug 1, 2020 160
Proactive news headlines: Tiziana Life Sciences, Thor Mining, ReNeuron, SkinBioTherapeutics ... Aug 1, 2020 2292
Tiziana Life Sciences makes patent application covering nasally-administered and orally taken Foralumab; shares spike 24%. Aug 1, 2020 460
Tiziana Life Sciences 'very excited' about potential for nasal delivery of Foralumab for coronavirus. Aug 1, 2020 158
Optimizing management of advanced urothelial carcinoma: A review of emerging therapies and biomarker-driven patient selection. Black, Peter C.; Alimohamed, Nimira S.; Berman, David; Blais, Normand; Eigl, Bernhard; Karakiewicz, Aug 1, 2020 7220
US FDA Grants Priority Review of Biologics License Application for Ansuvimab Ebola Treatment. Jul 31, 2020 332
National Institutes of Health Selects Humanigen's Lenzilumab for its COVID-19 Big Effect Trial. Jul 29, 2020 316
Taiwan-made antibodies show promise in treating coronavirus. Jul 29, 2020 585
Alector reports 'promising' preliminary data from AL001 Ph. 1b, Phase 2 studies. Jul 28, 2020 207
Humanigen says lenzilumab selected for National Institute of Health's upcoming coronavirus clinical trial. Jul 28, 2020 505
NA Proactive news snapshot: Humanigen, NetCents Technology, Talon Metals, Aftermath Silver, OTC Markets Group, Karora Resources UPDATE ... Jul 28, 2020 3109
Checkpoint Therapeutics to present cosibelimab interim results. Jul 27, 2020 288
NGM Biopharmaceuticals initiates Phase 2 CATALINA study of NGM621. Jul 27, 2020 210
Network Will Test Vaccines. Jul 27, 2020 375
Exonbio launches SARS-CoV-2 Nucleocapsid recombinant monoclonal antibodies for global IVD and research communities. Jul 24, 2020 170
Exonbio launches SARS-CoV-2 Nucleocapsid recombinant monoclonal antibodies for global IVD and research communities. Jul 24, 2020 174
Exonbio announces SARS-CoV-2 rabbit monoclonal antibodies to accelerate the fight against COVID-19. Jul 24, 2020 234
Exonbio announces SARS-CoV-2 rabbit monoclonal antibodies to accelerate the fight against COVID-19. Jul 24, 2020 230
Alector doses first patient in Phase 3 INFRONT-3 trial of AL001. Jul 24, 2020 242
GlaxoSmithKline takes stake in German vaccine group targeted by Donald Trump. Jul 21, 2020 594
Tiziana Life Sciences has potential to 'revolutionise treatment in monoclonal antibodies market'. Jul 21, 2020 163
Staten partners with Novo Nordisk to dose SST-5058 in first healthy volunteer for treatment of dyslipidaemia. Jul 21, 2020 213
Staten partners with Novo Nordisk to dose SST-5058 in first healthy volunteer for treatment of dyslipidaemia. Jul 21, 2020 209
Cerecor enrolls first patient in multicenter PoC study of CERC-002. Jul 21, 2020 276
Tiziana Life Sciences has potential to 'revolutionise treatment in monoclonal antibodies market'. Jul 21, 2020 161
Glaxo To Invest In Germany's CureVac As Partner To Develop Vaccines. Jul 20, 2020 362
GlaxoSmithKline announces vaccine pact with Germany's CureVac. Jul 20, 2020 253
Tiziana Life Sciences' move into CAR-T therapy has "intriguing implications", says influential Wall Street analyst. Jul 18, 2020 503
Tiziana Life Sciences CEO talks expansion into CAR-T therapy with novel proprietary approach. Jul 18, 2020 152
Tiziana Life Sciences' move into CAR-T therapy has "intriguing implications", says influential Wall Street analyst. Jul 18, 2020 505
Tiziana Life Sciences expands its oncology pipeline into CART-T therapy space. Jul 17, 2020 479
Tiziana Life Sciences expands its oncology pipeline into CART-T therapy space. Jul 17, 2020 481
Oracle partners with NIH to support vaccine trials in fight against COVID-19. Jul 17, 2020 171
Oracle partners with NIH to support vaccine trials in fight against COVID-19. Jul 17, 2020 165
Oracle partners with NIH to support vaccine trials in fight against COVID-19. Jul 17, 2020 169
Tonix Pharmaceuticals anounces research collaboration with Columbia University. Jul 16, 2020 238
Humanigen Expands Partnership with Catalent Biologics to Manufacture Investigational COVID-19 Therapeutic Candidate Lenzilumab. Jul 16, 2020 435
Kitov Pharma initiates NT219 clinical trial. Jul 9, 2020 266
Aboundbio announces clinical development licence agreement for potent human antibodies against the SARS-CoV-2 virus with SaudiVax Ltd. Jul 8, 2020 206
Aboundbio announces clinical development licence agreement for potent human antibodies against the SARS-CoV-2 virus with SaudiVax Ltd. Jul 8, 2020 202
Corvus Pharmaceuticals initiates study to investigate immunotherapy for COVID-19. Jul 7, 2020 594
In Fight Against COVID-19, CSL Behring Begins Trial to Evaluate Monoclonal Antibody (CSL312) for Respiratory Distress. Jul 7, 2020 462
In Fight Against COVID-19, CSL Behring Begins Trial to Evaluate Monoclonal Antibody for Respiratory Distress. Jul 6, 2020 569
CGRPs in real world: Similar efficacy, more adverse events. Kirkner, Richard Mark Jul 1, 2020 539
SSH: A Tool for Predicting Hydrophobic Interaction of Monoclonal Antibodies Using Sequences. Dzisoo, Anthony Mackitz; Kang, Juanjuan; Yao, Pengcheng; Klugah-Brown, Benjamin; Mengesha, Birga Ant Jun 30, 2020 3370
Role of Neutrophils in Psoriasis. Wang, Wen-Ming; Jin, Hong-Zhong Jun 30, 2020 4377
Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy. Irabu, Hitoshi; Shimizu, Masaki; Kaneko, Shuya; Inoue, Natsumi; Mizuta, Mao; Ohta, Kazuhide; Yachie, Jun 30, 2020 4675
Oncternal Therapeutics increases planned enrollment in cirmtuzumab trial. Jun 30, 2020 539
Oncternal Therapeutics announces orphan drug designations of cirmtuzumab by FDA. Jun 30, 2020 178
Y-mAbs initiates submission of BLA for omburtamab in 'FDA rolling review. Jun 30, 2020 211
Tiziana Life Sciences "aggressively advancing" COVID-19 treatment and breakthrough delivery method. Jun 30, 2020 603
Tiziana Life Sciences to fast track development of its coronavirus antibody & inhalation technology. Jun 30, 2020 178
Tiziana Life Sciences "aggressively advancing" COVID-19 treatment and breakthrough delivery method. Jun 30, 2020 605
Tiziana Life Sciences to fast track development of its coronavirus antibody & inhalation technology. Jun 30, 2020 180
Tiziana announces agreement with STC Biologics for manufacturing of TZLS-501. Jun 29, 2020 191
FDA approves Genentech's Phesgo for HER2-positive breast cancer. Jun 29, 2020 208
Halozyme announces FDA approval of Roche's Phesgo with Enhanze technology. Jun 29, 2020 166
Saudi-US researchers in licensing deal over 'exciting' new COVID-19 treatment. NOOR NUGALI Jun 28, 2020 593
Ology Bioservices wins USD42.6m DOD contract to advance anti-botulinum neurotoxin monoclonal antibodies. Jun 26, 2020 226
Ology Bioservices wins USD42.6m DOD contract to advance anti-botulinum neurotoxin monoclonal antibodies. Jun 26, 2020 222
Aduro Biotech doses first patient in Phase 1 study of BION-1301. Jun 24, 2020 208
NMPA Accepts Bio-Thera Solutions' Biologics License Application for BAT1706, A Proposed Biosimilar to Avastin. Jun 23, 2020 477
Bio-Thera Solutions submits BAT1706 BLA with NMPA for multiple cancers. Jun 22, 2020 176
Bio-Thera Solutions submits BAT1706 BLA with NMPA for multiple cancers. Jun 22, 2020 180
aTyr Pharma presents preclinical research on NRP2 antibody effects. Jun 22, 2020 183
Tiziana Life Sciences wins significant patent for oral delivery of antibodies. Jun 20, 2020 178
Tiziana Life Sciences receives US patent protection for a potentially transformational oral delivery method for monoclonal antibody treatment. Jun 20, 2020 609
Tiziana Life Sciences wins significant patent for oral delivery of antibodies. Jun 20, 2020 176
Tiziana Life Sciences receives US patent protection for a potentially transformational oral delivery method for monoclonal antibody treatment. Jun 20, 2020 607
Tiziana Life Sciences outlines a busy schedule for 2020. Jun 19, 2020 499
Tiziana Life Sciences outlines a busy schedule for 2020. Jun 19, 2020 501
Tiziana Granted US Patent For Oral Administration Of Foralumab. Jun 19, 2020 196
Sanofi granted approval for Dupixent in China. Jun 19, 2020 188
Integral Molecular Provides Rapid Safety Testing of COVID-19 Antibody Therapeutics with its Membrane Proteome Array Technology. Jun 19, 2020 411
Kiniksa announces publication of clinical outcomes with mavrilimumab in COVID-19. Clinical report Jun 17, 2020 306
Active Motif reports launch of pre-print manuscript of recombinant human COVID-19 antibodies. Jun 16, 2020 195
Active Motif reports launch of pre-print manuscript of recombinant human COVID-19 antibodies. Jun 16, 2020 191
Monopar Therapeutics, NorthStar partners to develop RITs targeting COVID-19. Jun 16, 2020 281
Integral reports launch of rapid safety testing of COVID-19 antibody via Membrane Proteome Array technology. Jun 15, 2020 198
Integral reports launch of rapid safety testing of COVID-19 antibody via Membrane Proteome Array technology. Jun 15, 2020 202
Integral Molecular to implement Membrane Proteome Array technology for antibody specificity profiling for development of SARS-CoV-2 therapeutic antibodies. Jun 15, 2020 170
Integral Molecular to implement Membrane Proteome Array technology for antibody specificity profiling for development of SARS-CoV-2 therapeutic antibodies. Jun 15, 2020 174
Edesa Biotech receives expedited approval from Health Canada to begin EB05 study. Jun 15, 2020 258
Provention Bio announces extended follow-up data from "At-Risk" TN-10 study. Jun 15, 2020 200
Leap Therapeutics awarded FDA's orphan designation for DKN-01 for treating gastric and gastroesophageal junction cancer. Jun 12, 2020 195
US FDA grants orphan drug designation to Leap Therapeutics' DKN-01. Jun 12, 2020 154
Leap Therapeutics awarded FDA's orphan designation for DKN-01 for treating gastric and gastroesophageal junction cancer. Jun 12, 2020 199
Integral Molecular Provides Rapid Safety Testing of COVID-19 Antibody Therapeutics with its Membrane Proteome Array Technology. Jun 12, 2020 411
Tychan to Begin First Clinical Trials for First Novel Monoclonal Antibody Against COVID-19. Jun 11, 2020 480
Tychan to Begin First Clinical Trials for First Novel Monoclonal Antibody Against COVID-19. Jun 10, 2020 480
AstraZeneca in deals with academia, US agencies on coronavirus antibodies. Jun 9, 2020 272
Kiniksa announces 28-day outcomes data from mavrilimumab treatment protocol. Clinical report Jun 8, 2020 432
AbbVie, Harbour BioMed, Utrecht University and Erasmus Medical Center forms partnership to develop monoclonal antibody therapy to prevent and treat COVID-19. Jun 8, 2020 185
AbbVie, Harbour BioMed, Utrecht University and Erasmus Medical Center forms partnership to develop monoclonal antibody therapy to prevent and treat COVID-19. Jun 8, 2020 189
China begins clinical trials of neutralising antibody Covid-19 treatment. Jun 7, 2020 404
Antibody drugs could help curb pandemic, Barron's says. Jun 6, 2020 162
AbbVie, Harbour BioMed, Utrecht University and Erasmus Medical Center Team to Develop Monoclonal Antibody Therapy to Prevent and Treat COVID-19. Jun 5, 2020 227
Biogen presents Phase 2 cutaneous lupus erythematosus data. Jun 4, 2020 379
Humanigen announces pricing of $72M private placement as it advances lenzilumab to treat cytokine storm in coronavirus patients. Jun 3, 2020 339
Eli Lilly doses patients in first study of COVID-19 Antibody Treatment LY-CoV555. Jun 2, 2020 163
Eli Lilly doses patients in first study of COVID-19 Antibody Treatment LY-CoV555. Jun 2, 2020 167
Merck, Junshi Biosciences collaborate to explore head, neck cancer treatment. Jun 1, 2020 204
NYU Langone Enrolls Patients in Clinical Trial for COVID-19 Antibody Therapy. Jun 1, 2020 300
Onset of Inflammatory Bowel Disease Following Interleukin-17A Inhibitor Treatment. Yazisiz, Veli; Ucar, Ismail; Aslan, Bengisu; Erbasan, Funda; Terzioglu, Mustafa Ender Letter to the editor Jun 1, 2020 1102
Immunocheckpoint Inhibitor- (Nivolumab-) Associated Hypereosinophilia in Non-Small-Cell Lung Carcinoma. Singh, Navdeep; Singh Lubana, Sandeep; Constantinou, George; Leaf, Andrea N. May 31, 2020 3548
Aveo Pharmaceuticals DEDUCTIVE trial advances to Phase 2 portion. May 29, 2020 205
Gilead announces updated results from magrolimab trial. May 29, 2020 305
Vir Biotechnology, Biogen enter agreement to manufacture SARS-CoV-2 antibodies. May 29, 2020 215
Allogene Therapeutics reports results from Phase 1 ALPHA study of ALLO-501. Report May 29, 2020 568
TG Therapeutics announces final results of GENUINE Phase 3 study. Clinical report May 29, 2020 290
Virna Therapeutics Teams with University of Toronto on Licensing of Neutralizing Monoclonal Antibodies to Treat COVID-19. May 28, 2020 376
Cerecor announces FDA clearance of IND for CERC-002. May 28, 2020 296
Taiwan scientists find antibody that fights coronavirus. May 28, 2020 353
Vir Biotechnology initiates Phase 1 trial of VIR-3434 for chronic HBV. May 27, 2020 227
Innovent doses first patient in China with Anti-TIGIT monoclonal antibody. May 26, 2020 191
Innovent doses first patient in China with Anti-TIGIT monoclonal antibody. May 26, 2020 187
Innovent Biologics doses first China patient in phase one clinical trial. May 26, 2020 289
Innovent Biologics doses first China patient in phase one clinical trial. May 26, 2020 285
Regeneron, Sanofi announce FDA approval of Dupixent for children. May 26, 2020 153
Kitov announces FDA acceptance of IND application for Phase 1/2 trial of NT219. May 22, 2020 319
Innovent Biologics, The University of Texas MD Anderson Cancer Center sign contract to co-develop TYVYT. May 19, 2020 216
Innovent Biologics, The University of Texas MD Anderson Cancer Center sign contract to co-develop TYVYT. May 19, 2020 212
Sanofi announces FDA priority review of sutimlimab. May 14, 2020 171
Kitov Pharmaceuticals to present Phase 1 data on CM-24. May 14, 2020 199
AstraZeneca regains rights to Brazikumab from Allergan. May 12, 2020 196
AstraZeneca regains rights to Brazikumab from Allergan. May 12, 2020 192
Kiniksa reports data for mavrilimumab in COVID-19 pneumonia. May 11, 2020 323
FastForward Innovations portfolio company says cancer therapy developer meets milestone. May 7, 2020 307
Momenta announces program updates. May 7, 2020 577
Vanderbilt University Medical Center, IDBiologics Team to Develop Breakthrough Medicines for COVID-19. May 7, 2020 428
Aridis Pharmaceuticals announces first COVID-19 VAP patient in ongoing Phase 3 AR-301 clinical trial. May 4, 2020 213
Aridis Pharmaceuticals announces first COVID-19 VAP patient in ongoing Phase 3 AR-301 clinical trial. May 4, 2020 209
TG Therapeutics announces publication from trial evaluating ublituximab. May 1, 2020 315
Human dental follicle mesenchymal stem cells alleviate T cell response in inflamed tissue of Crohn's patients. Zibandeh, Noushin; Genc, Deniz; Duran, Yazgul; Banzragch, Munhtsetseg; Sokwala, Sakina; Goker, Kamil May 1, 2020 5516
Human dental follicle mesenchymal stem cells alleviate T cell response in inflamed tissue of Crohn's patients. Zibandeh, Noushin; Genc, Deniz; Duran, Yazgul; Banzragch, Munhtsetseg; Sokwala, Sakina; Goker, Kamil May 1, 2020 4852
Tiziana Life Sciences files patent for combinational treatment for coronavirus. Apr 28, 2020 192
Tiziana Life Sciences files patent application for potential coronavirus treatment. Apr 28, 2020 382
Tiziana Life Sciences upbeat on potential for coronavirus treatment. Apr 28, 2020 427
Tiziana Life Sciences files patent for combinational treatment for coronavirus. Apr 28, 2020 190
Tiziana Life Sciences files patent application for potential coronavirus treatment. Apr 28, 2020 380
Tiziana Life Sciences upbeat on potential for coronavirus treatment. Apr 28, 2020 425
ThermoGenesis partners with ImmuneCyte to develop several convalescent plasma and antibody therapeutic approaches against COVID-19. Apr 27, 2020 178
ThermoGenesis partners with ImmuneCyte to develop several convalescent plasma and antibody therapeutic approaches against COVID-19. Apr 27, 2020 174
Tiziana Life files patent on combination of NP-ACT D, anti-IL-6R. Apr 27, 2020 318
ThermoGenesis-ImmuneCyte JV's COVID-19 therapies featured in news. Apr 24, 2020 155
GlaxoSmithKline presents GARNET study demonstrating potential of Dostarlimab. Apr 23, 2020 194
Innovent Biologics, Eli Lilly announce NMPA of China accepts NDA for Tyvyt. Apr 23, 2020 240
Kiniksa says Phase 2 trial of vixarelimab meets primary efficacy endpoint. Apr 22, 2020 277
Harbour BioMed completes first patient dosing in Phase 1b/2a study of Batoclimab. Apr 22, 2020 168
Harbour BioMed completes first patient dosing in Phase 1b/2a study of Batoclimab. Apr 22, 2020 164
Mabspace Biosciences (Suzhou) receives FDA approval for Claudin 18.2 (CLDN18.2) IND. Apr 21, 2020 237
Mabspace Biosciences (Suzhou) receives FDA approval for Claudin 18.2 (CLDN18.2) IND. Apr 21, 2020 241
Check Point issued U.S. composition of matter patent for cosibelimab. Apr 21, 2020 193
Checkpoint issued U.S. composition of matter patent for cosibelimab. Apr 21, 2020 193
Edesa Biotech announces license agreement to develop COVID-19 related treatments. Apr 20, 2020 213
Joint Venture To Develop Antibody Therapeutics For COVID-19. Apr 20, 2020 473
Role of Ki 67 Labelling Index as an Adjunct to Histopathological Diagnosis for Grading of CNS Tumours. Rai, Priyanka; Krishnani, Chandni; Goswami, S.S. Apr 20, 2020 3983
Pressure BioSciences and RedShiftBio join forces to create biopharmaceutical development tool. Apr 17, 2020 678
Tiziana Life Sciences files patent application for its novel coronavirus treatment technology. Apr 10, 2020 155
Small Cap Wrap - Chariot Oil & Gas; Tiziana Life Sciences; Advanced Oncotherapy; Silence Therapeutics and more.. Apr 10, 2020 1460
Tiziana Life Sciences upbeat on potential for coronavirus treatment. Apr 10, 2020 373
Tiziana Life Sciences files patent application for its novel coronavirus treatment technology. Apr 10, 2020 153
Small Cap Wrap - Chariot Oil & Gas; Tiziana Life Sciences; Advanced Oncotherapy; Silence Therapeutics and more.. Apr 10, 2020 1458
Tiziana Life Sciences upbeat on potential for coronavirus treatment. Apr 10, 2020 371
Samsung wins contract to produce COVID-19 treatments. Apr 10, 2020 647
Tiziana Life Sciences Shares Double On Covid-19 Treatment News. Apr 9, 2020 306
Regeneron, Zai Lab collaborate to commercialize REGN1979. Apr 8, 2020 199
Regeneron, Zai Lab announce collaboration for development of REGN1979. Apr 8, 2020 201
Ergomed to help run second trial in Italy targeting possible coronavirus treatments. Apr 7, 2020 273
GlaxoSmithKline, Vir Biotechnology collaborate for coronavirus solutions. Apr 6, 2020 355
Ergomed highlights first data from coronavirus study at Bergamo in Italy. Apr 3, 2020 364
Macromoltek offers computational de novo antibody design targeting COVID-19. Apr 2, 2020 153
Macromoltek offers computational de novo antibody design targeting COVID-19. Apr 2, 2020 157
Monoclonal Antibodies as an Antibacterial Approach Against Bacterial Pathogens. Zurawski, Daniel V.; McLendon, Molly K. Report Apr 1, 2020 7226
BEYOND PSORIASIS: Dermatology therapies have evolved as knowledge and investment grow. Kilgore, Christine Apr 1, 2020 2389
Astragalus membranaceus-Derived Anti-Programmed Death-1 Monoclonal Antibodies with Immunomodulatory Therapeutic Effects against Tumors. Chang, Fu-Ling; Tsai, Keng-Chang; Lin, Tsai-Yu; Yang, Tz-Wen; Lo, Yan-Ni; Chen, Wang-Chuan; Chang, J Mar 31, 2020 6162
MicroRNA-200a Promotes Phagocytosis of Macrophages and Suppresses Cell Proliferation, Migration, and Invasion in Nasopharyngeal Carcinoma by Targeting CD47. Zhao, Yunteng; Yu, Xiaoxiao; Tang, Haocheng; Han, Ri; Wang, Xianwen; Wang, Jianqi; Wang, Ke; Li, Gan Mar 31, 2020 5552
Development of an Enzyme-Linked Immunosorbent Assay Method for the Detection of Rhein in Rheum officinale. Chen, Min; Nan, Tie-Gui; Xin, Jie; Cui, Li; Zhang, Bo; Wang, Xiao; Wang, Bao-Min Mar 31, 2020 4203
Kiniksa announces evidence of treatment response with mavrilimumab. Mar 31, 2020 481
Humanigen poised to partner with leading contract research organization on Phase III trial to tackle deadly coronavirus. Mar 31, 2020 481
LifeMax Launches AmMax Bio, Licenses Monoclonal Antibody from Amgen. Mar 31, 2020 227
Generation Bio and Vir biotechnology Will on Research to Leverage Scalable Non-Viral Gene Therapy Platform for Use Against SARS-CoV-2Coronavirus. Mar 31, 2020 526
Regeneron announces presentation of detailed Phase 3 results of evinacumab trial. Mar 30, 2020 207
Humanigen moves a step closer to a Phase III trial to tackle leading cause of death in coronavirus. Mar 28, 2020 364
Vir proceeding with two clinical development candidates for COVID-19. Mar 25, 2020 485
Sorrento Therapeutics, SmartPharm collaborate to develop vaccine for COVID-19. Mar 23, 2020 213
EUSA Pharma, Italy's Papa Giovanni XXIII Hospital Launch Case-control Study of Siltuximab in Patients with COVID-19. Mar 19, 2020 428
Ergomed reveals it is providing clinical research services for a study in Italy for the treatment of patients with coronavirus. Mar 19, 2020 295
Roivant Sciences engages regulators in US, Europe, and Asia to advance Gimsilumab's clinical development. Mar 19, 2020 209
Roivant Sciences engages regulators in US, Europe, and Asia to advance Gimsilumab's clinical development. Mar 19, 2020 213
Regeneron partners with Sanofi to launch global Kevzara clinical trial programme for COVID-19. Mar 18, 2020 272
Regeneron partners with Sanofi to launch global Kevzara clinical trial programme for COVID-19. Mar 18, 2020 276
Aslan Pharmaceuticals reports Q4 EPS (7c), consensus (17c). Financial report Mar 18, 2020 173
Samsung Biologics forges Alzheimer's drug development partnership with Taiwan firm. Mar 17, 2020 470
Sanofi, Regeneron begin global Kevzara clinical trial program. Mar 16, 2020 209
Tiziana Life Sciences to "expedite development" of a drug that it believes could help COVID-19 patients with severe lung damage. Mar 12, 2020 395
Tiziana Life Sciences to "expedite development" of a drug that it believes could help COVID-19 patients with severe lung damage. Mar 12, 2020 397
Proactive news snapshot: Tiziana Life Sciences, Greatland Gold,Aa Europa Metals, Touchstone Exploration ... Mar 12, 2020 1115
Positive Recommendation by NICE for First Anti-CGRP Migraine Therapy Ajovy. Mar 12, 2020 634
Oncternal Therapeutics announces interim clinical data update for cirmtuzumab. Mar 11, 2020 214
Vir Biotechnology announces research collaboration with NIH VRC. Mar 11, 2020 270
Taiwan's Academia Sinica rebuffs China's claim to coronavirus test antibodies. Mar 10, 2020 429
Harbour BioMed Receives US FDA IND Approval for Phase 2 Clinical Trial and Orphan Drug. Mar 4, 2020 421
Atomic agency produces medical isotope for cancer treatment. Mar 4, 2020 440
Taiho Pharmaceutical Exercises Option for an Exclusive License to Zimberelimab for Its Territories in Japan and Other Asian Countries. Mar 3, 2020 700
Development and Evaluation of an Immuno-Capture Enzyme-Linked Immunosorbent Assay to Quantify the Mycoplasma capricolum subsp. capripneumoniae (Mccp) Protein in Contagious Caprine Pleuropneumonia (CCPP) Vaccine. Baziki, Jean de Dieu; Charles, Bodjo S.; Nwankpa, Nick; Maina, Naomi; Chitsungo, Ethel; Boukary, Cis Mar 1, 2020 6519
A Case of Psoriasis Vulgaris Treated with Brodalumab in a Hemodialysis Patient with End-Stage Renal Disease due to Diabetic Nephropathy. Ishibashi, Masafumi; Shiiyama, Rie Mar 1, 2020 1474
Pembrolizumab-Induced Mobitz Type 2 Second-Degree Atrioventricular Block. Khan, Alisha; Riaz, Sana; Carhart, Robert, Jr. Mar 1, 2020 1999
Upregulation of CD146 in Pediatric B-Cell Acute Lymphocytic Leukemia and Its Implications on Treatment Outcomes. Zahran, Asmaa M.; Badawy, Omnia El-; Elsayh, Khalid I.; Mohamed, Wael M.Y.; Riad, Khalid F.; Abdel-R Mar 1, 2020 5316
Beximco Pharma to market Mylan products in Bangladesh. Feb 27, 2020 299
Dyadic stages bid to combat coronavirus via partnership with The Israel Institute for Biological Research. Feb 26, 2020 387
Aimmune Licenses Exclusive Worldwide Rights to Xencor's XmAb7195 for the Development of Next-Generation Food Allergy Treatments. Feb 11, 2020 425
Bio-Thera Solutions Touts Positive Top-Line Results for BAT1706, A Proposed Biosimilar to Avastin. Feb 5, 2020 406
PSORIASIS: A look back over the past 50 years, and forward to next steps. Worcester, Sharon Feb 1, 2020 2098
Bimekizumab's impact on quality of life measure reported. Jancin, Bruce Feb 1, 2020 710
Global Monoclonal Antibodies (MAbs) Market / Industry Future Trends, Revenue Growth, and Leading Players. Jan 28, 2020 555
2020 Global Respiratory Syncytial Virus Diagnostics Market: DNA Probes, Monoclonal Antibodies, Immunoassays, IT & Other Technologies. Jan 24, 2020 314
The New England Journal of Medicine Publishes Comprehensive Data from Phase 3 Clinical Trial (OPTIC) of Tapezza for Thyroid Eye Disease. Jan 24, 2020 237
Vir Biotech 'Aggressively Working' On Potential Wuhan Coronavirus Treatment. Shanthi Rexaline Jan 23, 2020 280
Global Hematology and Flow Cytometry Markets - 2020. Jan 22, 2020 199
Scancell surges as it inks third collaboration deal for AvidiMab technology. Jan 21, 2020 225
Cancer Immunotherapy Market Size Is Expected to Reach USD 101.6 Billion at a 14.8% CAGR By 2023. Jan 21, 2020 860
US FDA approves Merck's Keytruda for specific bladder cancers. Jan 10, 2020 167
US FDA approves Merck's Keytruda for specific bladder cancers. Jan 10, 2020 163
TOT BIOPHARM Biological Drug R&D Project Makes List of National Major Scientific and Technological Special Projects for "Significant New Drug Development". Jan 2, 2020 371
Intravitreal Injection of Anti-VEGF Antibody Induces Glomerular Endothelial Cells Injury. Touzani, F.; Geers, C.; Pozdzik, A. Jan 1, 2020 1870
Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues. Kind, Simon; Merenkow, Christina; Buscheck, Franziska; Moller, Katharina; Dum, David; Chirico, Vikto Jan 1, 2020 7375
Herpes Simplex Virus Pneumonia: Importance of Aspiration Etiology. Odani, Kentaro; Tachibana, Mitsuhiro; Tamashima, Rintaro; Tsutsumi, Yutaka Dec 31, 2019 1682
43 kDa Glycoprotein (gp43) from Paracoccidioides brasiliensis Induced IL-17A and PGE2 Production by Human Polymorphonuclear Neutrophils: Involvement of TLR2 and TLR4. Gardizani, Taiane Priscila; Coletta, Amanda Manoel Della; Romagnoli, Graziela Gorete; Puccia, Rosana Dec 31, 2019 5790
Interleukin-17: Potential Target for Chronic Wounds. Hadian, Yasmin; Bagood, Michelle D.; Dahle, Sara E.; Sood, Apra; Isseroff, R. Rivkah Dec 31, 2019 7298
Amgen and Allergan submit ABP 798 BLA with FDA. Dec 20, 2019 217
Amgen and Allergan submit ABP 798 BLA with FDA. Dec 20, 2019 213
Monoclonal Antibodies (MAbS) Market 2020: Estimation & Forecast By Major Companies (Johnson & Johnson, Merck, AbbVie, Amgen and Glaxosmithkline plc) / Radiant Insights, Inc. Dec 19, 2019 883
Shandong Fontacea reports launch of license agreement with Janssen for Anti-IL17A monoclonal antibody. Dec 18, 2019 180
Shandong Fontacea reports launch of license agreement with Janssen for Anti-IL17A monoclonal antibody. Dec 18, 2019 176
Croatia Tumor Marker Sales Segment Forecasts for over 40 Tests: Monoclonal Antibodies, DNA Probes, AI & Biosensors. Dec 18, 2019 575

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters